Is a combination of verapamil and an ACE-inhibitor the optimal solution in ischaemic heart failure?
Jespersen
C M
CM
Cardiovascular Laboratory P, University of Copenhagen, Gentofte Hospital, Hellerup, Denmark.
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000008:administration & dosage*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy / Q000209:etiology; D002121:Calcium Channel Blockers / Q000008:administration & dosage*; D002986:Clinical Trials as Topic; D004359:Drug Therapy, Combination; D006801:Humans; D009203:Myocardial Infarction / Q000150:complications / Q000188:drug therapy / Q000209:etiology; D017202:Myocardial Ischemia / Q000150:complications / Q000188:drug therapy*; D014700:Verapamil / Q000008:administration & dosage*
D000806:Angiotensin-Converting Enzyme Inhibitors; D002121:Calcium Channel Blockers; D014700:Verapamil